Headache News and Research

Latest Headache News and Research

New drug combination more effective than the previous generation of hepatitis C/HIV therapy

A new study reveals the highest efficacy rates ever reported among patients co-infected with hepatitis C and HIV treated with pegylated interferon and ribavirin.

28 Jul 2004

Definite link between migraine and menstruation

Two new studies shows a definite link between migraine and menstruation. Approximately half of all women who seek clinical treatment for migraines have reported an association between migraine and menstruation, and a recent study by the City of London Migraine Clinic confirms their experience.

26 Jul 2004

California's first human death from West Nile virus (WNV)

West Nile virus (WNV) has claimed the life of a 57-year old Orange County man, making him the first to die in California from the virus, Dr. Richard Joseph Jackson, state public health officer, announced today.

26 Jul 2004

First human case of West Nile virus in Pennsylvania this year

The Pennsylvania Health Department today reported the first human case of West Nile virus in Pennsylvania this year. The individual is a 36-year-old Bucks County man.

26 Jul 2004

Botox approved as treatment for severe underarm sweating

The FDA has approved Botulinum Toxin Type A (Botox) to treat severe underarm sweating known as “primary axillary hyperhidrosis” that cannot be managed by topical agents such as prescription antiperspirants. Botox has already been approved for several other purposes.

20 Jul 2004

Virginia mans dies from Hantavirus disease

The Virginia Department of Health announced last week that a man from the New River Health District in Southwest Virginia has died from Hantavirus disease.

19 Jul 2004

Study suggests that weather patterns can bring on headaches

Headache, a peer-reviewed journal published on behalf of the American Headache Society, features the most carefully done study on the influence of weather patterns on headache.

16 Jul 2004

Vermont Department of Health reports that a Chittenden County toddler died over the weekend from meningococcal disease

The child, who attended Ed-U-Care Children's Center in Essex Junction, became ill on Saturday night, was taken to the hospital and died early Sunday morning.

13 Jul 2004

Human antibodies that thwart the SARS virus in mice can be mass-produced quickly

Human antibodies that thwart the SARS virus in mice can be mass-produced quickly using a new laboratory technique developed by an international research team collaborating with the National Institute of Allergy and Infectious Diseases (NIAID).

12 Jul 2004

The case of a high school student in King County who died this week of meningococcal disease has created public concern

The case of a high school student in King County who was hospitalized and died this week of meningococcal disease – commonly called bacterial meningitis – has created some public concern about risks of exposure to the disease.

10 Jul 2004

Meningococcal disease: peak season warning

West Australians are being urged to watch out for the signs and symptoms of meningococcal disease as the State heads into the peak season for the potentially deadly infection.

28 Jun 2004

Aggressive treatment of brain blood clots can produce a good outcome for many stroke patients

In the study, published in a recent issue of the journal Neurosurgery, 50 percent of stroke patients had little or no neurological disability one to three months after clot-dissolving medication was delivered directly to the site of the blockages, compared to 39 percent of patients with similarly good outcomes documented in a large national trial of intravenous (IV) drug treatment for stroke.

21 Jun 2004

Fairfax student dies after a four-day hospitalization for meningitis/encephalitis

A 16-year old Chantilly high school student died last week after a four-day hospitalization for meningitis/encephalitis. The cause does not appear to be bacterial meningitis. However, an autopsy is pending and investigation is underway.

20 Jun 2004

Results from study of Rituxan in rheumatoid arthritis show promise

Genentech, Inc., Biogen Idec and Roche have announced that the New England Journal of Medicine published the results of a Phase IIa study showing that two doses of Rituxan® (Rituximab), administered two weeks apart, improved symptoms in patients with moderate-to-severe rheumatoid arthritis (RA) for up to 48 weeks when combined with methotrexate (MTX), compared to MTX alone.

16 Jun 2004

Kids as young as 6 who get frequent headaches may be using over-the-counter pain relievers too much

Kids as young as 6 who get frequent headaches may be using over-the-counter pain relievers far more than they should, and often without their parents' knowledge, suggests a study being presented at the 46th Annual Scientific Meeting of the American Headache Society (AHS).

11 Jun 2004

Dead birds collected in five northern Illinois counties have tested positive for West Nile virus

Dead birds collected in five northern Illinois counties have tested positive for West Nile virus, Dr. Eric E. Whitaker, state public health director, today announced.

11 Jun 2004

Arizona advisory on tick removal

As hotter temperatures draw Arizonans to the state’s high country, Department of Health Services Director Catherine Eden advised residents to take precautions against tick bites because some ticks carry germs that cause disease, including Rocky Mountain spotted fever.

11 Jun 2004

U.S. team to battle malaria in Peru

In the middle of the Peruvian Amazon, a battle against malaria – the second largest killer of people worldwide – will be undertaken by an international team of researchers led by tropical disease specialist Joseph Vinetz, M.D., from the University of California, San Diego (UCSD) School of Medicine.

11 Jun 2004

America's first two WNV encephalitis cases of 2004 respond to treatment

GenoMed, Inc. has announced that the country's second case of West Nile virus encephalitis has responded promptly to its treatment approach. So far, GenoMed's treatment is showing a 100% response rate among 13 immunocompetent patients. The sooner the treatment is instituted, the more rapid and more complete the response.

10 Jun 2004

Untreated transient ischemic attacks put 21,000 Canadians at increased risk of death, stroke or heart attack

The Canadian Heart and Stroke Foundation warns that untreated transient ischemic attacks (TIAs) are putting nearly 21,000 Canadians at increased risk of death, stroke or heart attack.

9 Jun 2004

Headache News and Research

Latest Headache News and Research

New drug combination more effective than the previous generation of hepatitis C/HIV therapy

Definite link between migraine and menstruation

California's first human death from West Nile virus (WNV)

First human case of West Nile virus in Pennsylvania this year

Botox approved as treatment for severe underarm sweating

Virginia mans dies from Hantavirus disease

Study suggests that weather patterns can bring on headaches

Vermont Department of Health reports that a Chittenden County toddler died over the weekend from meningococcal disease

Human antibodies that thwart the SARS virus in mice can be mass-produced quickly

The case of a high school student in King County who died this week of meningococcal disease has created public concern

Meningococcal disease: peak season warning

Aggressive treatment of brain blood clots can produce a good outcome for many stroke patients

Fairfax student dies after a four-day hospitalization for meningitis/encephalitis

Results from study of Rituxan in rheumatoid arthritis show promise

Kids as young as 6 who get frequent headaches may be using over-the-counter pain relievers too much

Dead birds collected in five northern Illinois counties have tested positive for West Nile virus

Arizona advisory on tick removal

U.S. team to battle malaria in Peru

America's first two WNV encephalitis cases of 2004 respond to treatment

Untreated transient ischemic attacks put 21,000 Canadians at increased risk of death, stroke or heart attack

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Headache News and Research

Latest Headache News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in